Page last updated: 2024-09-04

mk 767 and ly 465608

mk 767 has been researched along with ly 465608 in 3 studies

Compound Research Comparison

Studies (mk 767)	Trials (mk 767)	Recent Studies (post-2010) (mk 767)	Studies (ly 465608)	Trials (ly 465608)	Recent Studies (post-2010) (ly 465608)
32	0	10	7	0	0

Protein Interaction Comparison

Protein	Taxonomy	ly 465608 (IC50)
Peroxisome proliferator-activated receptor gamma	Homo sapiens (human)	0.548
Peroxisome proliferator-activated receptor alpha	Homo sapiens (human)	0.174
ATP-binding cassette sub-family C member 8	Homo sapiens (human)	0.548
ATP-sensitive inward rectifier potassium channel 11	Homo sapiens (human)	0.548

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ardecky, R; Broderick, CL; Brooks, DA; Dominianni, SJ; Etgen, GJ; Faul, MM; Karanewsky, DS; Kauffman, RF; McCarthy, JR; Montrose-Rafizadeh, C; Oldham, BA; Paterniti, JR; Rito, CJ; Shuker, AJ; Tyhonas, J; Warshawsky, AM; Winneroski, LL	1
Deussen, HJ; Ebdrup, S; Fleckner, J; Frost Jensen, A; Mortensen, SB; Nygaard, L; Pettersson, I; Pridal, L; Rasmussen, HB; Sauerberg, P	1
Henke, BR	1

Reviews

1 review(s) available for mk 767 and ly 465608

Article	Year
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes. Journal of medicinal chemistry, 2004, Aug-12, Volume: 47, Issue:17 Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Models, Molecular; Molecular Structure; Receptors, Cytoplasmic and Nuclear; Transcription Factors	2004

Other Studies

2 other study(ies) available for mk 767 and ly 465608

Article	Year
Design and synthesis of 2-methyl-2-[4-(2-[5-methyl-2-aryloxazol-4-yl]ethoxy)phenoxy]propionic acids: a new class of dual PPARalpha/gamma agonists. Journal of medicinal chemistry, 2001, Jun-21, Volume: 44, Issue:13 Topics: Animals; Blood Glucose; Cholesterol, HDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Design; Hypoglycemic Agents; Mice; Mice, Inbred Strains; Propionates; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Triglycerides	2001
Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazar. Journal of medicinal chemistry, 2003, Apr-10, Volume: 46, Issue:8 Topics: Binding Sites; Crystallography, X-Ray; Hypoglycemic Agents; Ligands; Models, Molecular; Oxazines; Phenylpropionates; Radioligand Assay; Receptors, Cytoplasmic and Nuclear; Stereoisomerism; Transcription Factors	2003

Article

Year

Design and synthesis of 2-methyl-2-[4-(2-[5-methyl-2-aryloxazol-4-yl]ethoxy)phenoxy]propionic acids: a new class of dual PPARalpha/gamma agonists.

Journal of medicinal chemistry, 2001, Jun-21, Volume: 44, Issue:13

Topics: Animals; Blood Glucose; Cholesterol, HDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Design; Hypoglycemic Agents; Mice; Mice, Inbred Strains; Propionates; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Triglycerides

2001

Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazar.

Journal of medicinal chemistry, 2003, Apr-10, Volume: 46, Issue:8

Topics: Binding Sites; Crystallography, X-Ray; Hypoglycemic Agents; Ligands; Models, Molecular; Oxazines; Phenylpropionates; Radioligand Assay; Receptors, Cytoplasmic and Nuclear; Stereoisomerism; Transcription Factors

2003